[Federal Register Volume 74, Number 80 (Tuesday, April 28, 2009)]
[Notices]
[Pages 19228-19229]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-9686]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Software Systems to Facilitate the Use of 
Electronic Data Records.
    Date: April 30, 2009.
    Time: 1 p.m. to 2:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 706, Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Kirt Vener, PhD, Branch Chief, Special Review 
and Logistics Branch, Division of Extramural Activities, National 
Cancer Institute, NIH, 6116 Executive Blvd., Room 8061, Bethesda, MD 
20892-8329, 301-496-7174, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to scheduling conflicts.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Glycan Arrays for Biomarker Discovery and Validation.
    Date: May 22, 2009.
    Time: 10 a.m. to 12 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 706, Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Adriana Stoica, PhD, Scientific Review Officer, 
Special Review & Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd, Ste 
703, Rm 7072, Bethesda, MD 20892-8329. 301-594-1408. 
[email protected].


[[Page 19229]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Discovery and Development P01.
    Date: June 17-18, 2009.
    Time: 8:00 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Peter J. Wirth, PhD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8131, 
Bethesda, MD 20892-8328, 301-496-7565, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovative Technologies Development for Cancer Research.
    Date: July 7-8, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Adriana Stoica, PhD, Scientific Review Officer, 
Special Review & Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd, Ste 
703, Rm 7072, Bethesda, MD 20892-8329, 301-594-1408, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: April 22, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-9686 Filed 4-27-09; 8:45 am]
BILLING CODE 4140-01-P